Pembrolizumab Hope for Treatment-Resistant Advanced Melanoma

Antibody therapy against the programmed-death-Receptor-1 may help patients with advanced melanoma progression after ipilimumab and other targeted treatments...

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.